Page last updated: 2024-08-25

zoledronic acid and Hypercalcemia

zoledronic acid has been researched along with Hypercalcemia in 108 studies

Research

Studies (108)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (5.56)	18.2507
2000's	47 (43.52)	29.6817
2010's	42 (38.89)	24.3611
2020's	13 (12.04)	2.80

Authors

Authors	Studies
Bachmann, R; Bisping, M; Born, AR; Cortesi, R; Glatt, M; Green, JR; Guiglia, G; Jaeggi, KA; Jeker, H; Klein, R; Müller, K; Ramseier, U; Schmid, J; Schreiber, G; Seltenmeyer, Y; Widler, L	1
Chakhtoura, M; El-Hajj Fuleihan, G	1
Berns, JS; Geara, AS; Shulman, R	1
Çakır, Ö; Çizmecioğlu-Jones, FM; Demirsoy, U; Jones, JH; Kilci, F	1
Shane, E; Walker, MD	1
Lopes, MG; McNaught, KA; Morris, JS; Tosi, G	1
Bassatne, A; Drake, MT; El-Hajj Fuleihan, G; Murad, MH; Piggott, T; Rahme, M	1
Carsen, S; Feber, J; Khan, N; Konji, VN; Koujok, K; Molina, MO; Page, M; Rauch, F; Robinson, ME; Seale, E; Sheffield, H; Smit, K; Walker, S; Ward, LM	1
Faiq, S; Hu, T; Ku, G; Lavelle, K; Shoback, D	1
Cao, S; Jin, J; Luo, Y; Shan, X; Wu, H; Wu, Y; Zheng, Z	1
Kushima, C; Nakazato, M; Uchida, T; Yamaguchi, H; Yonekawa, T	1
Elazzazy, S; Hamad, A; Nasser, SM; Sahal, A	1
Colak, U; Hatun, S; Kayserili, H; Mutlu, GY; Sozmen, BO; Yucel, EB	1
Alvarado, M; Bueno, S; González, L; Ramírez, M; Sierra, M	1
Ntanasis-Stathopoulos, I; Terpos, E	1
Ebata, T; Ishiwata, T; Iwasawa, S; Saito, G; Takiguchi, Y; Tatsumi, K; Yoshino, I	1
Eltze, E; Zimmer, V	1
Bansal, B; Farooqui, KJ; Kuchay, MS; Mishra, SK; Mithal, A; Sekhar, L	1
Arase, H; Eriguchi, M; Fujisaki, K; Kitazono, T; Nakamura, M; Nakano, T; Okabe, Y; Tachibana, S; Tomita, K; Tsuruya, K; Yamada, S	1
Peña, S	1
Finazzo, F; Manzoni, P; Militello, MA; Re, MP; Vitaliti, G; Vitaliti, SM	1
Lightowlers, S; Patterson, D	1
Efthymiadou, A; Gkentzi, D; Karana-Ginopoulou, A; Kolyva, S; Varvarigou, A	1
Açıkgöz, Y; Aksoy, S; Ozdemir, NY; Sendur, MA; Uncu, D; Zengin, N	1
Kumar, G; Kumar, N; Sundriyal, D; Walia, M	1
Bezaury, AP; Nevarez-Barragan, MJ; Perez-Diaz, I; Rosas-Jurado, MG; Trejo-Rosales, R	1
Addissie, B; Kumar, R; Martens, P	1
Armanini, D; Bordin, L; Camozzi, V; Donà, G; Iacobone, M; Mian, C; Sabbadin, C	1
Body, JJ; Braun, A; Diel, IJ; Feng, A; Goldwasser, F; Spencer, A; Steger, G; Stopeck, AT; Vadhan-Raj, S; von Moos, R	1
Ananth, CV; Burke, WM; Chen, L; Hershman, DL; Hou, JY; Neugut, AI; Richards, CA; Tergas, AI; Wright, JD	1
Cheung, MS	1
George, S; Hummel, K; Kaplan, P; Levine, MA; Monk, HM; Weber, DR	1
Agarwal, A; Aung, TT; Strand, AO	1
Clark, SL; Nystrom, EM	1
Chang, B; Du, SX; Hu, QX; Li, XD; Lin, FX; Xie, D; Yu, GY; Zheng, GZ	1
Ato, M; Iwagami, M; Kano, S; Ota, N; Seki, T; Yamamoto, K	1
Agosto, S; Ahmadi, S; Bruder, JM; Koops, M; Toro-Tobón, D	1
Carcas, AJ; Cordoba, R; Hernandez-Navarro, F; Lei, SH; Lopez de la Guia, A; Ramirez, E; Sanjurjo, MJ	1
Linneman, T; McMahan, J	1
Alameda Hernando, C; Díaz Guardiola, P; Guijarro de Armas, G; Iglesias Bolaños, P; Pavón de Paz, I; Vega Piñero, B	1
Ericson, S; Gruia, G; Hohneker, J	1
Habib, EE; Sabry, NA	1
Boutrus, R; El-Attar, I; El-Hossieny, H; Kader, YA; Nazmy, M; Zaghloul, MS	1
Civantos Modino, S; Díaz Guardiola, P; Guijarro de Armas, MG; Montaño Martínez, JM; Pavón de Paz, I; Zubieta Tabernero, J	1
Fujikawa, Y; Kadoya, S; Matsumoto, Y; Murakami, N; Murasugi, K; Ohura, F; Tanabe, K; Yoshii, I	1
Argüelles Jiménez, I; Carrillo García, P; García Fernández, H; Quevedo Juanals, J; Serra Soler, G	1
Chiu, CF; Lin, PH; Lu, YS	1
Aksoy, S; Arık, Z; Ozdemir, NY; Sendur, MA; Uncu, D; Yaman, S; Zengin, N	1
Ludwig, H; Zojer, N	1
Imamura, F; Sakai, D; Sugimoto, N; Yagi, T; Yoshinami, T	1
Botteman, MF; Carter, JA; Joshi, AD; Kaura, S	1
Bensimon, AG; Ericson, SG; Guo, A; Marynchenko, M; Namjoshi, M; Raje, N; Wu, EQ; Yu, AP	1
Legrand, SB	1
Avgoustidis, N; Ioakeimidis, D; Karageorgas, TP	1
Henk, HJ; Kaura, S	1
Boikos, SA; Hammers, HJ	1
Tao, H; Wang, M; Wang, Y; Wang, Z; Yu, X	1
Hassali, MA; Hassan, BA; Othman, SB; Weiderpass, E; Yusoff, ZB	1
Edwards, S; Laing, K; McCarthy, J; McCrate, F; Murphy, L; Powell, E; Seal, M	1
Major, P	1
Goa, KL; Wellington, K	1
Cook, R; Major, PP	1
Berenson, JR	2
Ashcroft, AJ; Davies, FE; Morgan, GJ	1
Bigos, ST	1
Coleman, RE; Neville-Webbe, Hl	1
Davis, LE; Li, EC	1
Body, JJ	3
Fraser, WD; Mishra, V; Peter, R	1
Bartsch, R; Hussian, D; Locker, GJ; Pluschnig, U; Sevelda, U; Steger, GG; Wenzel, C; Zielinski, CC	1
Figgitt, DP; Perry, CM	1
Berenson, J; Hirschberg, R	1
Breay, S	1
Bergner, R; Diel, IJ	1
Inoue, K; Kawada, K; Minami, H; Okabe, K; Sasaki, T; Sawamura, M; Takashima, S; Watanabe, T; Yagi, Y	1
Khuri, F; Saba, N	1
Rexer, H	1
Barone, A; Foppiani, L; Palummeri, E; Prete, C; Senesi, B; Trasciatti, S; Veneziano, M	1
Balla, J	1
Lugassy, G	1
Etayo-Pérez, A; Garatea-Crelgo, J; Martino-Gorbea, R; Pastor-Zuazaga, D; Sebastián-López, C	1
Suzuki, M; Tomoo, T	1
Bian, SG; Jiang, ZF; Shen, G; Song, ST; Wang, JJ; Wang, YJ; Xie, GR	1
Inoue, K; Iwase, H; Kawazoe, T; Nagamoto, N; Nakahara, O; Ohsako, T; Sakamoto, N; Yamamoto, Y; Yoshida, Y	1
Chen, NL; Diaz-Borjon, A; Lim, SS; Seyler, TM	1
Bandeira, F; Colares, V; Griz, L	1
Sakurai, T	1
Barlogie, B; Elici, F; Gokden, N; Kumar, J; Zangari, M	1
Armstrong, A; Branstetter, D; Bussiere, J; Cowan, L; Dougall, WC; Jones, J; Kennedy, B; Miller, RE	1
Maxwell, C	1
Isaia, GC; Pellissetto, C; Ravazzoli, M; Tamone, C	1
Green, JR; Jaeggi, KA; Müller, K	1
Delmas, PD; Lipton, A	1
Delmas, PD	1
Green, J	1
Body, JJ; Ford, J; Lortholary, A; Romieu, G; Vigneron, AM	1
Coleman, RE	1
Abdi, E; Bell, R; Body, J; Hon, J; Lortholary, A; Major, P; Menssen, HD; Mills, G; Quebe-Fehling, E; Seaman, J; Yunus, F	1
Coleman, RE; Major, PP	1
Cheer, SM; Noble, S	1
Lortholary, A	1
Schwetz, BA	1
Davidson, TG	1
Heatley, S	1

Reviews

37 review(s) available for zoledronic acid and Hypercalcemia

Article	Year
Treatment of Hypercalcemia of Malignancy. Endocrinology and metabolism clinics of North America, 2021, Volume: 50, Issue:4 Topics: Bone Density Conservation Agents; Denosumab; Diphosphonates; Humans; Hypercalcemia; Neoplasms; Zoledronic Acid	2021
Hypercalcemia: A Review. JAMA, 2022, 10-25, Volume: 328, Issue:16 Topics: Calcium; Coma; COVID-19; Dehydration; Denosumab; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Immune Checkpoint Inhibitors; Nausea; Neoplasms; Pamidronate; Parathyroid Hormone; SARS-CoV-2; Sleepiness; Sodium Chloride Symporter Inhibitors; Vitamin A; Vitamin D; Vomiting; Zoledronic Acid	2022
Patient and Physician Decisional Factors Regarding Hypercalcemia of Malignancy Treatment: A Novel Mixed-Methods Study. The Journal of clinical endocrinology and metabolism, 2023, 02-15, Volume: 108, Issue:3 Topics: Adult; Cross-Sectional Studies; Diphosphonates; Humans; Hypercalcemia; Neoplasms; Quality of Life; Zoledronic Acid	2023
Controversies in the use of new bone-modifying therapies in multiple myeloma. British journal of haematology, 2021, Volume: 193, Issue:6 Topics: Bone Density Conservation Agents; COVID-19; Denosumab; Diphosphonates; Humans; Hypercalcemia; Multiple Myeloma; Osteolysis; Receptor Activator of Nuclear Factor-kappa B; Renal Insufficiency; Zoledronic Acid	2021
Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature. Journal of pediatric endocrinology & metabolism : JPEM, 2014, Volume: 27, Issue:3-4 Topics: Bone Density Conservation Agents; Bone Neoplasms; Child; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Zoledronic Acid	2014
Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review. BMC endocrine disorders, 2015, Jan-28, Volume: 15 Topics: Aged, 80 and over; Bone Density Conservation Agents; Calcimimetic Agents; Cinacalcet; Cushing Syndrome; Diphosphonates; Fluid Therapy; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperthyroidism; Imidazoles; Male; Parathyroidectomy; Zoledronic Acid	2015
Drugs Used in Paediatric Bone and Calcium Disorders. Endocrine development, 2015, Volume: 28 Topics: Acetazolamide; Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Calcitriol; Calcium; Child; Denosumab; Diphosphonates; Diuretics; Glucocorticoids; Humans; Hypercalcemia; Hyperphosphatemia; Hypocalcemia; Hypophosphatemia; Imidazoles; Osteoporosis; Parathyroid Hormone; Phosphates; Risedronic Acid; Sodium Potassium Chloride Symporter Inhibitors; Vitamin D; Zoledronic Acid	2015
Meta-analysis comparing denosumab and zoledronic acid for treatment of bone metastases in patients with advanced solid tumours. European journal of cancer care, 2017, Volume: 26, Issue:6 Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Denosumab; Diphosphonates; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Male; Orthopedic Procedures; Prostatic Neoplasms; Radiotherapy; Spinal Cord Compression; Zoledronic Acid	2017
Chronic Myeloid Leukemia Associated Hypercalcemia: A Case Report and Literature Review. The American journal of case reports, 2017, Feb-27, Volume: 18 Topics: Blast Crisis; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Humans; Hypercalcemia; Imidazoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Zoledronic Acid	2017
Supportive therapy in multiple myeloma. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2011, Volume: 183 Topics: Anemia; Blood Transfusion; Bone Diseases; Calcitonin; Clodronic Acid; Diphosphonates; Erythropoietin; Fractures, Bone; Hematinics; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Osteoporosis; Pamidronate; Recombinant Proteins; Renal Insufficiency; Zoledronic Acid	2011
Modern management of malignant hypercalcemia. The American journal of hospice & palliative care, 2011, Volume: 28, Issue:7 Topics: Bone Density Conservation Agents; Calcitonin; Clinical Protocols; Diphosphonates; Fluid Therapy; Gallium; Humans; Hypercalcemia; Imidazoles; Neoplasms; Palliative Care; Pamidronate; Parathyroid Hormone-Related Protein; Zoledronic Acid	2011
Systemic lupus erythematosus and hypercalcaemia: case report and brief review of the literature. Scandinavian journal of rheumatology, 2011, Volume: 40, Issue:5 Topics: Adult; Antibodies, Antinuclear; Bone Density Conservation Agents; Diphosphonates; Diuretics; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Imidazoles; Lupus Erythematosus, Systemic; Zoledronic Acid	2011
The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy. The oncologist, 2002, Volume: 7, Issue:6 Topics: Anti-Inflammatory Agents; Bone Resorption; Diphosphonates; Dose-Response Relationship, Drug; Humans; Hypercalcemia; Imidazoles; Neoplasms; Pamidronate; Randomized Controlled Trials as Topic; Treatment Outcome; Zoledronic Acid	2002
Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy. Drugs, 2003, Volume: 63, Issue:4 Topics: Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Drug Administration Schedule; Humans; Hypercalcemia; Imidazoles; Kidney; Zoledronic Acid	2003
Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints. American journal of clinical oncology, 2002, Volume: 25, Issue:6 Suppl 1 Topics: Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Data Interpretation, Statistical; Diphosphonates; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Male; Models, Statistical; Pain; Pamidronate; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid	2002
Treatment of hypercalcemia of malignancy with bisphosphonates. Seminars in oncology, 2002, Volume: 29, Issue:6 Suppl 21 Topics: Bone Resorption; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid	2002
Aetiology of bone disease and the role of bisphosphonates in multiple myeloma. The Lancet. Oncology, 2003, Volume: 4, Issue:5 Topics: Antineoplastic Agents; Bone and Bones; Bone Density; Bone Neoplasms; Chemokines; Clinical Trials as Topic; Clodronic Acid; Cytokines; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Osteolysis; Patient Selection; Treatment Outcome; Zoledronic Acid	2003
Selected therapy-related clinical research topics in osteoporosis. Journal of pediatric endocrinology & metabolism : JPEM, 2003, Volume: 16 Suppl 3 Topics: Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Female; Hip Fractures; Humans; Hypercalcemia; Imidazoles; Injections; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Osteoporosis; Zoledronic Acid	2003
The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia. Palliative medicine, 2003, Volume: 17, Issue:6 Topics: Bone Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Matrix Metalloproteinases; Randomized Controlled Trials as Topic; Zoledronic Acid	2003
Zoledronic acid: a new parenteral bisphosphonate. Clinical therapeutics, 2003, Volume: 25, Issue:11 Topics: Animals; Bone Diseases, Metabolic; Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Half-Life; Humans; Hypercalcemia; Imidazoles; Metabolic Clearance Rate; Neoplasms; Zoledronic Acid	2003
Hypercalcemia of malignancy. Seminars in nephrology, 2004, Volume: 24, Issue:1 Topics: Antineoplastic Agents; Diphosphonates; Forecasting; Humans; Hypercalcemia; Imidazoles; Neoplasms; Pamidronate; Parathyroid Hormone-Related Protein; Zoledronic Acid	2004
Zoledronic acid: a review of its use in patients with advanced cancer. Drugs, 2004, Volume: 64, Issue:11 Topics: Area Under Curve; Bone and Bones; Bone Neoplasms; Bone Resorption; Calcium; Diphosphonates; Drug Tolerance; Economics, Pharmaceutical; Female; Half-Life; Humans; Hypercalcemia; Imidazoles; Infusions, Intravenous; Male; Neoplasms; Randomized Controlled Trials as Topic; Zoledronic Acid	2004
Safety and convenience of a 15-minute infusion of zoledronic acid. The oncologist, 2004, Volume: 9, Issue:3 Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid	2004
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 2: Clinical studies and economic analyses. Oncology, 2005, Volume: 68, Issue:1 Topics: Antineoplastic Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Cost-Benefit Analysis; Diphosphonates; Drug Costs; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Lung Neoplasms; Multicenter Studies as Topic; Nerve Compression Syndromes; Pain; Spinal Cord Compression; United States; Zoledronic Acid	2005
Primary hyperparathyroidism and neuropsychiatric alterations in a nonagenarian woman. Aging clinical and experimental research, 2005, Volume: 17, Issue:1 Topics: Aged; Aged, 80 and over; Bone Diseases, Metabolic; Cognition Disorders; Diphosphonates; Disease Progression; Diuretics; Female; Humans; Hypercalcemia; Hyperparathyroidism; Imidazoles; Nervous System Diseases; Sodium Chloride; Treatment Outcome; Zoledronic Acid	2005
[Preclinical and clinical profile of zoledronic acid (Zometa) for hypercalcemia of malignancy]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2005, Volume: 126, Issue:5 Topics: Animals; Apoptosis; Bone Density Conservation Agents; Bone Resorption; Calcitriol; Cells, Cultured; Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Geranyltranstransferase; Humans; Hypercalcemia; Imidazoles; Neoplasms; Osteoclasts; Zoledronic Acid	2005
[Treatment of Paget's disease of bone: importance of the zoledronic acid]. Arquivos brasileiros de endocrinologia e metabologia, 2006, Volume: 50, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Resorption; Calcitonin; Diphosphonates; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Hypercalcemia; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Osteitis Deformans; Pamidronate; Remission Induction; Treatment Outcome; Zoledronic Acid	2006
[Therapeutic agents for disorders of bone and calcium metabolism: Zoledronic acid]. Clinical calcium, 2007, Volume: 17, Issue:1 Topics: Bone Density; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Male; Osteoporosis, Postmenopausal; Zoledronic Acid	2007
Clinical research update: zoledronate. Cancer, 1997, Oct-15, Volume: 80, Issue:8 Suppl Topics: Animals; Bone Neoplasms; Breast Neoplasms; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Mice; Multiple Myeloma; Rats; Zoledronic Acid	1997
Current and future directions in medical therapy: hypercalcemia. Cancer, 2000, Jun-15, Volume: 88, Issue:12 Suppl Topics: Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Zoledronic Acid	2000
Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jan-15, Volume: 19, Issue:2 Topics: Adult; Aged; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Neoplasms; Pamidronate; Randomized Controlled Trials as Topic; Zoledronic Acid	2001
Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program. Seminars in oncology, 2001, Volume: 28, Issue:2 Suppl 6 Topics: Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Zoledronic Acid	2001
Zoledronic acid. Drugs, 2001, Volume: 61, Issue:6 Topics: Animals; Bone and Bones; Bone Resorption; Calcium; Clinical Trials as Topic; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Neoplasms; Zoledronic Acid	2001
[Tumor-induced hypercalcemia. Review of bisphosphonate treatment]. La Revue de medecine interne, 2001, Volume: 22, Issue:7 Topics: Diagnosis, Differential; Diagnostic Errors; Diphosphonates; Etidronic Acid; Fluid Therapy; Hematologic Neoplasms; Humans; Hypercalcemia; Imidazoles; Neoplasms; Pamidronate; Prognosis; Recurrence; Sodium Chloride; Treatment Outcome; Zoledronic Acid	2001
Advances in the biology and treatment of myeloma bone disease. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001, Nov-15, Volume: 58 Suppl 3 Topics: Antineoplastic Agents; Bone Diseases; Bone Neoplasms; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Zoledronic Acid	2001
Conventional treatment of hypercalcemia of malignancy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001, Nov-15, Volume: 58 Suppl 3 Topics: Calcitonin; Clinical Protocols; Diphosphonates; Drug Costs; Fluid Therapy; Gallium; Humans; Hydrocortisone; Hypercalcemia; Imidazoles; Neoplasms; Nucleic Acid Synthesis Inhibitors; Plicamycin; Prednisone; Rehydration Solutions; Zoledronic Acid	2001
Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates. International journal of palliative nursing, 2001, Volume: 7, Issue:6 Topics: Bone Neoplasms; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Neoplasms; Pain; Zoledronic Acid	2001

Trials

9 trial(s) available for zoledronic acid and Hypercalcemia

Article	Year
The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease. European journal of cancer (Oxford, England : 1990), 2015, Volume: 51, Issue:11 Topics: Antibodies, Monoclonal, Humanized; Bone Neoplasms; Breast Neoplasms; Denosumab; Diphosphonates; Double-Blind Method; Female; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Multiple Myeloma; Neoplasms; Proportional Hazards Models; Zoledronic Acid	2015
Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study. Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:2 Topics: Adolescent; Adult; Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Young Adult; Zoledronic Acid	2011
A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer. International journal of clinical oncology, 2010, Volume: 15, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Drug Administration Schedule; Egypt; Female; Fractures, Bone; Humans; Hypercalcemia; Imidazoles; Kaplan-Meier Estimate; Male; Middle Aged; Pain; Placebo Effect; Prospective Studies; Risk Assessment; Risk Factors; Spinal Cord Compression; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Zoledronic Acid	2010
Cost-effectiveness of zoledronic acid in the management of skeletal metastases in patients with lung cancer in France, Germany, Portugal, the Netherlands, and the United kingdom. Clinical therapeutics, 2011, Volume: 33, Issue:3 Topics: Bone and Bones; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Cost-Benefit Analysis; Diphosphonates; Europe; Fractures, Bone; Health Care Costs; Humans; Hypercalcemia; Imidazoles; Lung Neoplasms; Middle Aged; Quality-Adjusted Life Years; Spinal Cord Compression; Zoledronic Acid	2011
Clinical significance of zoledronic acid and strontium-89 in patients with asymptomatic bone metastases from non-small-cell lung cancer. Clinical lung cancer, 2013, Volume: 14, Issue:3 Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Hypercalcemia; Imidazoles; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Syndromes; Spinal Cord Compression; Strontium; Zoledronic Acid	2013
A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:1 Topics: Adult; Aged; Breast Neoplasms; Calcium; Diphosphonates; Dose-Response Relationship, Drug; Female; Head and Neck Neoplasms; Humans; Hypercalcemia; Imidazoles; Lung Neoplasms; Male; Middle Aged; Multiple Myeloma; Neoplasms; Treatment Outcome; Zoledronic Acid	2005
[Use of zoledronic acid for high risk prostate cancer patients]. Der Urologe. Ausg. A, 2005, Volume: 44, Issue:2 Topics: Animals; Bone Neoplasms; Diphosphonates; Drug Administration Schedule; Europe; Humans; Hypercalcemia; Imidazoles; Injections, Intravenous; Male; Prostatic Neoplasms; Treatment Outcome; Zoledronic Acid	2005
A dose-finding study of zoledronate in hypercalcemic cancer patients. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1999, Volume: 14, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Diphosphonates; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Neoplasms; Zoledronic Acid	1999
Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program. Seminars in oncology, 2001, Volume: 28, Issue:2 Suppl 6 Topics: Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Zoledronic Acid	2001

Other Studies

63 other study(ies) available for zoledronic acid and Hypercalcemia

Article	Year
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa). Journal of medicinal chemistry, 2002, Aug-15, Volume: 45, Issue:17 Topics: Animals; Bone Resorption; Calcitriol; Diphosphonates; Hypercalcemia; Imidazoles; In Vitro Techniques; Kidney; Mice; Pamidronate; Parathyroidectomy; Rats; Skull; Structure-Activity Relationship; Thyroidectomy; Zoledronic Acid	2002
Pamidronate versus zoledronic acid for the treatment of multiple myeloma-related hypercalcemia. Kidney international, 2022, Volume: 101, Issue:5 Topics: Diphosphonates; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Pamidronate; Zoledronic Acid	2022
Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with zoledronic acid and Denosumab. Journal of pediatric endocrinology & metabolism : JPEM, 2022, Aug-26, Volume: 35, Issue:8 Topics: Adolescent; Bone Density Conservation Agents; Calcium; Child; Denosumab; Diphosphonates; Hormones, Ectopic; Humans; Hypercalcemia; Male; Parathyroid Hormone; Rhabdomyosarcoma; Zoledronic Acid	2022
Retrospective assessment of tolerability and efficacy of zoledronate in the palliative treatment of cancer-bearing dogs. Australian veterinary journal, 2023, Volume: 101, Issue:1-2 Topics: Animals; Calcium; Dog Diseases; Dogs; Hypercalcemia; Neoplasms; Pain; Palliative Care; Retrospective Studies; Zoledronic Acid	2023
Mitigating the Denosumab-Induced Rebound Phenomenon with Alternating Short- and Long-Acting Anti-resorptive Therapy in a Young Boy with Severe OI Type VI. Calcified tissue international, 2023, Volume: 112, Issue:5 Topics: Bone Density; Bone Density Conservation Agents; Calcium; Child; Denosumab; Humans; Hypercalcemia; Male; Osteogenesis Imperfecta; Zoledronic Acid	2023
Cinacalcet increases renal calcium excretion in PTHrP-mediated hypercalcemia: a case report. BMC endocrine disorders, 2023, Jun-16, Volume: 23, Issue:1 Topics: Calcium; Cinacalcet; Humans; Hypercalcemia; Male; Middle Aged; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Zoledronic Acid	2023
Successful treatment of hypercalcemia in a Chinese patient with a novel homozygous mutation in the CYP24A1 gene using zoledronic acid: a case report. Journal of pediatric endocrinology & metabolism : JPEM, 2023, Sep-26, Volume: 36, Issue:9 Topics: Calcium; East Asian People; Female; Humans; Hypercalcemia; Infant; Mutation; Vitamin D3 24-Hydroxylase; Zoledronic Acid	2023
Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab. Endocrine journal, 2020, Jan-28, Volume: 67, Issue:1 Topics: Ankle; Anorexia; Antithyroid Agents; Aromatase Inhibitors; Arthralgia; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Collagen Type I; Denosumab; Deprescriptions; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Graves Disease; Humans; Hypercalcemia; Methimazole; Middle Aged; Parathyroid Hormone; Peptides; Potassium Iodide; Radionuclide Imaging; Tartrate-Resistant Acid Phosphatase; Thirst; Zoledronic Acid	2020
Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:8 Topics: Bone Density Conservation Agents; Bone Neoplasms; Calcium; Cohort Studies; Denosumab; Female; Humans; Hypercalcemia; Hypocalcemia; Incidence; Male; Middle Aged; Retrospective Studies; Zoledronic Acid	2019
Zoledronate-responsive calcitriol-mediated hypercalcemia in a 5-year-old case with squamous cell carcinoma on the background of xeroderma pigmentosum. Journal of pediatric endocrinology & metabolism : JPEM, 2019, Dec-18, Volume: 32, Issue:12 Topics: Bone Density Conservation Agents; Calcitriol; Carcinoma, Squamous Cell; Child, Preschool; Humans; Hypercalcemia; Male; Paraneoplastic Syndromes; Prognosis; Xeroderma Pigmentosum; Zoledronic Acid	2019
Hypercalcemia of Malignancy in a Patient with Hypoparathyroidism: A Complicated but Treatable Condition. Puerto Rico health sciences journal, 2019, Volume: 38, Issue:4 Topics: Bone Density Conservation Agents; Calcitriol; Diphosphonates; Eye Neoplasms; Humans; Hypercalcemia; Hypoparathyroidism; Male; Melanoma; Middle Aged; Noonan Syndrome; Zoledronic Acid	2019
Risk factors for skeletal-related events in non-small cell lung cancer patients treated with bone-modifying agents. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021, Volume: 29, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Denosumab; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Spinal Cord Compression; Zoledronic Acid	2021
Parathyroid Hormone-Related Peptide (PTHrp)-Secreting Liver Metastatic Large-Cell Neuroendocrine Carcinoma of the Sigmoid Colon. The American journal of medicine, 2021, Volume: 134, Issue:9 Topics: Aged; Biopsy; Bone Density Conservation Agents; Carcinoma, Neuroendocrine; Colon, Sigmoid; Colonic Neoplasms; Colonoscopy; Humans; Hypercalcemia; Liver Neoplasms; Male; Neoplasm Grading; Neoplasm Staging; Paraneoplastic Syndromes; Parathyroid Hormone-Related Protein; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid	2021
Glucocorticoid sparing effect of zoledronic acid in sarcoid hypercalcemia. Archives of osteoporosis, 2017, Volume: 12, Issue:1 Topics: Administration, Oral; Adult; Diphosphonates; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hypercalcemia; Imidazoles; Middle Aged; Sarcoidosis; Zoledronic Acid	2017
Immobilization-induced severe hypercalcaemia successfully treated with reduced dose of zoledronate in a maintenance haemodialysis patient. Nephrology (Carlton, Vic.), 2018, Volume: 23, Issue:10 Topics: Adult; Bed Rest; Bedridden Persons; Biomarkers; Bone Density Conservation Agents; Calcium; Humans; Hypercalcemia; Male; Renal Dialysis; Severity of Illness Index; Treatment Outcome; Up-Regulation; Zoledronic Acid	2018
What is causing this patient's hypercalcemia? JAAPA : official journal of the American Academy of Physician Assistants, 2019, Volume: 32, Issue:5 Topics: Abdominal Pain; Diagnosis, Differential; Fatal Outcome; Female; Humans; Hypercalcemia; Middle Aged; Neoplasms, Unknown Primary; Psychotherapy, Brief; Sodium Chloride; Tomography, X-Ray Computed; Zoledronic Acid	2019
Use of Zoledronic Acid in a Neonate with Subcutaneous Fat Necrosis Complicated with Severe, Refractory Hypercalcemia. American journal of perinatology, 2019, Volume: 36, Issue:S 02 Topics: Bone Density Conservation Agents; Calcium; Drug Resistance; Fat Necrosis; Female; Furosemide; Glucocorticoids; Humans; Hypercalcemia; Infant, Newborn; Methylprednisolone; Sodium Potassium Chloride Symporter Inhibitors; Subcutaneous Fat; Term Birth; Zoledronic Acid	2019
Mismanagement of malignant hypercalcaemia. Clinical medicine (London, England), 2013, Volume: 13, Issue:1 Topics: Bone Density Conservation Agents; Calcium; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Malpractice; Neoplasms; Zoledronic Acid	2013
Longest survival of lung metastatic ameloblastoma with a rare cause of malignant hypercalcemia. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2014, Volume: 42, Issue:4 Topics: Ameloblastoma; Bone Density Conservation Agents; Diphosphonates; Follow-Up Studies; Humans; Hypercalcemia; Imidazoles; Lung Neoplasms; Male; Mandibular Neoplasms; Middle Aged; Polydipsia; Polyuria; Treatment Refusal; Zoledronic Acid	2014
Livedo reticularis heralding hypercalcaemia of malignancy. BMJ case reports, 2014, May-15, Volume: 2014 Topics: Calcitonin; Carcinoma, Squamous Cell; Diphosphonates; Diuretics; Fluid Therapy; Follow-Up Studies; Humans; Hypercalcemia; Imidazoles; Livedo Reticularis; Male; Middle Aged; Monitoring, Physiologic; Mouth Neoplasms; Risk Assessment; Treatment Outcome; Zoledronic Acid	2014
Rare association between penile squamous cell carcinoma and parathyroid related peptide (PTH-rP) secretion. Arquivos brasileiros de endocrinologia e metabologia, 2014, Volume: 58, Issue:6 Topics: Bone Density Conservation Agents; Carcinoma, Squamous Cell; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Parathyroid Hormone; Pelvis; Penile Neoplasms; Rare Diseases; Tomography, X-Ray Computed; Zoledronic Acid	2014
Follicular lymphoma presenting with hypercalcaemia: an unusual mechanism of hypercalcaemia. Acta clinica Belgica, 2015, Volume: 70, Issue:3 Topics: Aged; Bone Density Conservation Agents; Calcitonin; Chemokines; Cytokines; Diphosphonates; Diuretics; Female; Furosemide; Humans; Hypercalcemia; Imidazoles; Lymphoma, Follicular; Neoplasm Staging; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Parotid Gland; Positron-Emission Tomography; Sentinel Lymph Node Biopsy; Sodium Chloride; Vitamin D; Zoledronic Acid	2015
Quality and Outcomes of Treatment of Hypercalcemia of Malignancy. Cancer investigation, 2015, Volume: 33, Issue:8 Topics: Aged; Bone Neoplasms; Calcitonin; Diphosphonates; Diuretics; Female; Glucocorticoids; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Multivariate Analysis; Neoplasms; Pamidronate; Quality of Health Care; Treatment Outcome; Zoledronic Acid	2015
Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience. The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:11 Topics: Acute-Phase Reaction; Adolescent; Alkaline Phosphatase; Bone Density Conservation Agents; Bone Diseases; Calcitriol; Calcium; Child; Child, Preschool; Diphosphonates; Female; Humans; Hypercalcemia; Hypocalcemia; Hypophosphatemia; Imidazoles; Infant; Male; Osteogenesis Imperfecta; Osteoporosis; Prospective Studies; Retrospective Studies; Risk Factors; Young Adult; Zoledronic Acid	2015
Not all ST-segment changes are myocardial injury: hypercalcaemia-induced ST-segment elevation. BMJ case reports, 2015, Oct-13, Volume: 2015 Topics: Aged, 80 and over; Bone Density Conservation Agents; Brugada Syndrome; Cardiac Conduction System Disease; Diagnosis, Differential; Diphosphonates; Diuretics; Echocardiography; Electrocardiography; Follow-Up Studies; Furosemide; Humans; Hypercalcemia; Imidazoles; Male; Multiple Myeloma; Myocardial Ischemia; Point-of-Care Testing; Treatment Outcome; Zoledronic Acid	2015
A Case of Severe, Prolonged, Refractory Hypophosphatemia After Zoledronic Acid Administration. Journal of pharmacy practice, 2016, Volume: 29, Issue:2 Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Hypercalcemia; Hypophosphatemia; Imidazoles; Male; Middle Aged; Paraneoplastic Syndromes; Zoledronic Acid	2016
Dual antiplasmodial activity of vitamin D3 and its analog, 22-oxacalcitriol, by direct and indirect mechanisms. Parasitology international, 2017, Volume: 66, Issue:2 Topics: Acute Disease; Animals; Antimalarials; Body Weight; Calcitriol; Cholecalciferol; Chronic Disease; Diphosphonates; Erythrocytes; Humans; Hypercalcemia; Imidazoles; Interferon-gamma; Malaria; Mice; Mice, Inbred BALB C; Mice, Knockout; Parasitemia; Plasmodium chabaudi; Receptors, Calcitriol; Zoledronic Acid	2017
Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acid. European journal of clinical pharmacology, 2008, Volume: 64, Issue:10 Topics: Adult; Antineoplastic Agents; Diphosphonates; Drug Interactions; Drug Therapy, Combination; Humans; Hypercalcemia; Imidazoles; Itraconazole; Leukemia, Promyelocytic, Acute; Male; Treatment Outcome; Tretinoin; Zoledronic Acid	2008
A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:9 Topics: Aged; Algorithms; Bone Density Conservation Agents; Calcitonin; Carcinoma, Transitional Cell; Crystalloid Solutions; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Isotonic Solutions; Male; Neoplasm Metastasis; Pamidronate; Ureteral Neoplasms; Zoledronic Acid	2009
[Primary hyperparathyroidism. An alternative to the surgery]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:3 Topics: Adenoma; Aged, 80 and over; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Cinacalcet; Comorbidity; Contraindications; Diphosphonates; Drug Therapy, Combination; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Kidney Function Tests; Kidney Neoplasms; Naphthalenes; Parathyroid Neoplasms; Parathyroidectomy; Treatment Refusal; Zoledronic Acid	2009
FDA drug information that never reaches clinicians. The New England journal of medicine, 2010, Feb-11, Volume: 362, Issue:6 Topics: Diphosphonates; Drug Approval; Drug Industry; Drug Labeling; Humans; Hypercalcemia; Imidazoles; Kidney Diseases; United States; United States Food and Drug Administration; Zoledronic Acid	2010
[Primary hyperparathyroidism in a patient with Paget's bone disease]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57, Issue:4 Topics: Adenoma; Aged; Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Diphosphonates; Female; Humans; Hypercalcemia; Hyperparathyroidism; Imidazoles; Osteitis Deformans; Osteoporosis; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Radionuclide Imaging; Zoledronic Acid	2010
[A case report of a patient treatable by home palliative care, administered zoledronic acid used for bladder cancer with hypercalcemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:5 Topics: Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Fatal Outcome; Female; Home Care Services; Humans; Hypercalcemia; Imidazoles; Palliative Care; Terminal Care; Urinary Bladder Neoplasms; Zoledronic Acid	2010
[Parathyroid crisis due to a cystic parathyroid adenoma]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:3 Topics: Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitonin; Colectomy; Colonic Diseases; Consciousness Disorders; Cysts; Diagnostic Imaging; Diphosphonates; Emergencies; Female; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Imidazoles; Intestinal Perforation; Kidney Calculi; Middle Aged; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Thyroidectomy; Zoledronic Acid	2011
Cisplatin as an active treatment in zoledronate-refractory hypercalcemia. Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:5 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cisplatin; Diphosphonates; Female; Fluorouracil; Humans; Hypercalcemia; Imidazoles; Leucovorin; Middle Aged; Neoplasm Recurrence, Local; Treatment Failure; Vinblastine; Vinorelbine; Zoledronic Acid	2011
Small cell carcinoma of the urinary bladder with hypercalcemia. Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Carcinoma, Small Cell; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Middle Aged; Treatment Outcome; Urinary Bladder Neoplasms; Zoledronic Acid	2012
A case of acquired Fanconi syndrome induced by zoledronic acid. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Fanconi Syndrome; Female; Humans; Hypercalcemia; Imidazoles; Kidney Function Tests; Middle Aged; Zoledronic Acid	2011
Comparison of skeletal complications and treatment patterns associated with early vs. delayed zoledronic acid therapy in multiple myeloma. Clinical lymphoma, myeloma & leukemia, 2011, Volume: 11, Issue:4 Topics: Aged; Bone Density Conservation Agents; Bone Diseases; Bone Diseases, Metabolic; Comorbidity; Diphosphonates; Drug Administration Schedule; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Proportional Hazards Models; Retrospective Studies; Spinal Cord Compression; Zoledronic Acid	2011
Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mortality in women with breast cancer and bone metastasis in a managed care plan. Journal of medical economics, 2012, Volume: 15, Issue:1 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Databases, Factual; Diphosphonates; Female; Fractures, Bone; Humans; Hypercalcemia; Imidazoles; Insurance Claim Review; Medicare Part C; Middle Aged; Outcome Assessment, Health Care; Retrospective Studies; Spinal Cord Compression; United States; Zoledronic Acid	2012
Denosumab for the treatment of bisphosphonate-refractory hypercalcemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Oct-10, Volume: 30, Issue:29 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Neoplasms; Carcinoma, Renal Cell; Denosumab; Diphosphonates; Disease Progression; Drug Resistance; Fatal Outcome; Humans; Hypercalcemia; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Parathyroid Hormone; Risk Assessment; Zoledronic Acid	2012
Impact of chemotherapy on hypercalcemia in breast and lung cancer patients. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Calcium; Chi-Square Distribution; Cisplatin; Cyclophosphamide; Deoxycytidine; Diphosphonates; Docetaxel; Epirubicin; Female; Fluorouracil; Gemcitabine; Humans; Hypercalcemia; Imidazoles; Linear Models; Logistic Models; Lung Neoplasms; Male; Middle Aged; Pamidronate; Parathyroid Hormone-Related Protein; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Taxoids; Young Adult; Zoledronic Acid	2012
Use of bisphosphonates in metastatic breast cancer: single institution review at the Dr. H. Bliss Murphy Cancer Centre. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Cancer Care Facilities; Diphosphonates; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Middle Aged; Pamidronate; Registries; Retrospective Studies; Spinal Cord Compression; Zoledronic Acid	2013
Severe hypocalcaemia after being given intravenous bisphosphonate. BMJ (Clinical research ed.), 2004, Feb-07, Volume: 328, Issue:7435 Topics: Bone Resorption; Diphosphonates; Female; Humans; Hypercalcemia; Hypocalcemia; Imidazoles; Male; Middle Aged; Neoplasms; Zoledronic Acid	2004
Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:9 Topics: Bone Resorption; Breast Neoplasms; Diphosphonates; Drug Resistance; Female; Humans; Hypercalcemia; Imidazoles; Liver Neoplasms; Middle Aged; Neoplasm Metastasis; Pamidronate; Quality of Life; Recurrence; Zoledronic Acid	2004
Hypocalcaemia after intravenous bisphosphonate: read the product information first. BMJ (Clinical research ed.), 2004, Jun-12, Volume: 328, Issue:7453 Topics: Diphosphonates; Drug Labeling; Humans; Hypercalcemia; Hypocalcemia; Imidazoles; Infusions, Intravenous; Zoledronic Acid	2004
Re: Berenson J, Hirschberg R. Safety and convenience of a 15-minute infusion of zoledronic acid. The oncologist, 2005, Volume: 10, Issue:1 Topics: Bone Neoplasms; Creatinine; Diphosphonates; Half-Life; Humans; Hypercalcemia; Imidazoles; Infusions, Intravenous; Kidney; Safety; Zoledronic Acid	2005
The issue of renal safety of zoledronic acid from a nephrologist's point of view. The oncologist, 2005, Volume: 10, Issue:5 Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid	2005
"Safety and convenience of a 15-minute infusion of zoledronic acid": not so safe. The oncologist, 2005, Volume: 10, Issue:5 Topics: Antineoplastic Agents; Bone Neoplasms; Clodronic Acid; Diphosphonates; Humans; Hypercalcemia; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Pamidronate; Time Factors; Zoledronic Acid	2005
Osteonecrosis of the jaws and bisphosphonates. Report of three cases. Medicina oral, patologia oral y cirugia bucal, 2006, Jan-01, Volume: 11, Issue:1 Topics: Aged; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Jaw Diseases; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Tooth Extraction; Zoledronic Acid	2006
[Clinical study of zoledronic acid in the treatment of cancer-induced hypercalcemia]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2005, Volume: 27, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Male; Middle Aged; Neoplasms; Safety; Zoledronic Acid	2005
[Two cases of stage IV breast cancer with severe hypercalcemia]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2 Topics: Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Goserelin; Humans; Hypercalcemia; Imidazoles; Leuprolide; Lymph Nodes; Lymphatic Metastasis; Paclitaxel; Quality of Life; Tamoxifen; Zoledronic Acid	2006
Bisphosphonate-associated arthritis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2006, Volume: 12, Issue:3 Topics: Arthritis; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Fatal Outcome; Female; Humans; Hypercalcemia; Imidazoles; Infusions, Intravenous; Middle Aged; Pamidronate; Zoledronic Acid	2006
Potential effect of zoledronate therapy in heavy proteinuria. Clinical nephrology, 2007, Volume: 67, Issue:4 Topics: Biopsy; Bone Density Conservation Agents; Diphosphonates; Female; Glucocorticoids; Humans; Hypercalcemia; Imidazoles; Middle Aged; Multiple Myeloma; Prednisone; Proteinuria; Zoledronic Acid	2007
Receptor activator of NF-kappa B ligand inhibition suppresses bone resorption and hypercalcemia but does not affect host immune responses to influenza infection. Journal of immunology (Baltimore, Md. : 1950), 2007, Jul-01, Volume: 179, Issue:1 Topics: Animals; Bone Resorption; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Immunologic; Female; Hydroxycholecalciferols; Hypercalcemia; Imidazoles; Immunity, Innate; Immunoglobulin G; Influenza A Virus, H3N2 Subtype; Longitudinal Studies; Male; Mice; Mice, Inbred C57BL; Orthomyxoviridae Infections; Osteoprotegerin; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Recombinant Fusion Proteins; Zoledronic Acid	2007
Role of the nurse in preserving patients' independence. European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2007, Volume: 11 Suppl 2 Topics: Activities of Daily Living; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Documentation; Drug Monitoring; Humans; Hypercalcemia; Imidazoles; Nurse's Role; Nursing Assessment; Nursing Records; Oncology Nursing; Pain; Patient Compliance; Patient Education as Topic; Social Support; Treatment Outcome; Zoledronic Acid	2007
Acute adrenal crisis and hypercalcemia in a patient assuming high liquorice doses. Minerva medica, 2008, Volume: 99, Issue:1 Topics: Adrenal Cortex Hormones; Adrenal Insufficiency; Adrenalectomy; Alkalosis; Anti-Inflammatory Agents; Bone Density Conservation Agents; Diphosphonates; Female; Glycyrrhiza; Humans; Hydrocortisone; Hyperaldosteronism; Hypercalcemia; Hypernatremia; Hypokalemia; Imidazoles; Middle Aged; Zoledronic Acid	2008
Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1994, Volume: 9, Issue:5 Topics: Animals; Bone and Bones; Bone Density; Bone Resorption; Calcitriol; Calcium; Diphosphonates; Drug Evaluation, Preclinical; Hypercalcemia; Imidazoles; Interleukin-1; Male; Mice; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Parathyroidectomy; Peptide Fragments; Proteins; Rats; Thyroidectomy; Zoledronic Acid	1994
Pamidronate (Aredia) and zoledronate: update on clinical results. Introduction. British journal of clinical practice. Supplement, 1996, Volume: 87 Topics: Bone Neoplasms; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Organophosphorus Compounds; Osteoblasts; Pamidronate; Zoledronic Acid	1996
Zoledronate. British journal of clinical practice. Supplement, 1996, Volume: 87 Topics: Bone Neoplasms; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Osteitis Deformans; Osteoporosis; Zoledronic Acid	1996
Zoledronate: the preclinical pharmacology. British journal of clinical practice. Supplement, 1996, Volume: 87 Topics: Animals; Bone Resorption; Cholecalciferol; Depression, Chemical; Diphosphonates; Disease Models, Animal; Female; Hypercalcemia; Imidazoles; Ovariectomy; Pamidronate; Parathyroidectomy; Rats; Thyroidectomy; Zoledronic Acid	1996
Optimising treatment of bone metastases by Aredia(TM) and Zometa(TM). Breast cancer (Tokyo, Japan), 2000, Volume: 7, Issue:4 Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Hypercalcemia; Imidazoles; Male; Osteoclasts; Osteoporosis; Pamidronate; Prostatic Neoplasms; Zoledronic Acid	2000
From the Food and Drug Administration. JAMA, 2001, Oct-03, Volume: 286, Issue:13 Topics: Atrial Natriuretic Factor; Cardiotonic Agents; Diphosphonates; Equipment Reuse; Heart Failure; Humans; Hypercalcemia; Imidazoles; Natriuretic Peptide, Brain; Neoplasms; United States; United States Food and Drug Administration; Zoledronic Acid	2001
New bisphosphonic acid approved by FDA. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2001, Oct-01, Volume: 58, Issue:19 Topics: Diphosphonates; Drug Approval; Humans; Hypercalcemia; Imidazoles; Neoplasm Proteins; Neoplasms; Parathyroid Hormone-Related Protein; United States; United States Food and Drug Administration; Zoledronic Acid	2001